Grégoire Courtine
Gründer bei ONWARD MEDICAL N.V.
Vermögen: 4 Mio $ am 30.04.2024
Aktive Positionen von Grégoire Courtine
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ONWARD MEDICAL N.V. | Direktor/Vorstandsmitglied | 01.01.2014 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 | - | |
Gründer | 01.01.2014 | - | |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Direktor/Vorstandsmitglied | 01.12.2014 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.12.2014 | - | |
Gründer | 01.12.2014 | - | |
Vertrieb & Marketing | 01.12.2014 | - | |
Swiss Federal Institute of Technology | Corporate Officer/Principal | - | - |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Grégoire Courtine
Ehemalige bekannte Positionen von Grégoire Courtine
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NeuroRestore
NeuroRestore Pharmaceuticals: MajorHealth Technology NeuroRestore is a platform of symptom-relieving drug candidates for disease states in which cognitive ability is impaired, such as Alzheimer's disease, sleep apnea, traumatic brain injury, and Parkinson's disease. NeuroRestore is based in Lausanne, Switzerland. The Swiss company stimulates specific signaling pathways in the central nervous system known as neurotrophins, which play a crucial role in the function of nerve cells. The most well-known neurotrophins are NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor). NeuroRestore's drug candidates enhance communication between nerve cells and improve cognitive ability. The private company's leading drug candidate, ACD856, has recently completed clinical phase I studies and demonstrated positive effects. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Grégoire Courtine
University of Pavia | Doctorate Degree |
Statistik
International
Schweiz | 4 |
Italien | 2 |
Deutschland | 2 |
Operativ
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ONWARD MEDICAL N.V. | Commercial Services |
Private Unternehmen | 3 |
---|---|
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Health Services |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Health Technology |
NeuroRestore
NeuroRestore Pharmaceuticals: MajorHealth Technology NeuroRestore is a platform of symptom-relieving drug candidates for disease states in which cognitive ability is impaired, such as Alzheimer's disease, sleep apnea, traumatic brain injury, and Parkinson's disease. NeuroRestore is based in Lausanne, Switzerland. The Swiss company stimulates specific signaling pathways in the central nervous system known as neurotrophins, which play a crucial role in the function of nerve cells. The most well-known neurotrophins are NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor). NeuroRestore's drug candidates enhance communication between nerve cells and improve cognitive ability. The private company's leading drug candidate, ACD856, has recently completed clinical phase I studies and demonstrated positive effects. | Health Technology |
- Börse
- Insiders
- Grégoire Courtine
- Erfahrung